Excision Versus Preservation of Spermatic Cord Lipoma Detected During Subinguinal Varicocelectomy

NCT ID: NCT06257459

Last Updated: 2024-02-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

200 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-01-01

Study Completion Date

2024-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In the current study, the adult infertile patients with clinical varicoceles will be included. the patients will undergo subinguinal varicocelectomy. The patients with spermatic cord lipoma detected at the time of surgery will be enrolled and divided into 2 groups( excision group, group A and preservation group (B). semen parameters will be compared in both group at 3 and 6 months after surgery

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This will be a prospective randomized study, in which adult infertile patients with clinical varicocele and oligo-athenospermia admitted to Urology department Tanta university hospital will be included and then the patients with detected spermatic cord lipoma at the time surgery will be enrolled and divided into 2 groups:

GROUP A : will undergo subinguinal varicocelectomy with excision of spermatic cord lipoma GROUP B : will undergo subinguinal varicocelectomy with preservation of spermatic cord lipoma

Inclusion criteria:

* Adult infertile males
* Clinical varicocele
* oligo-asthenospermia

Exclusion criteria:

* Adolescent varicocele
* Recurrent varicocele
* Presence of inguinal hernia
* Azospermic patients

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Male Infertility

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Lipoma Excision (group A)

excison of spermatic cord lipoma detected during subinguinal varicocelectomy in infertile males

Group Type ACTIVE_COMPARATOR

subinguinal varicocelectomy

Intervention Type PROCEDURE

exision or preservation of spermatic cord lipoma during subinguinal varicocelectomy

Lipoma Preservation (group B)

preservation of spermatic cord lipoma detected during subinguinal varicocelectomy in infertile males

Group Type ACTIVE_COMPARATOR

subinguinal varicocelectomy

Intervention Type PROCEDURE

exision or preservation of spermatic cord lipoma during subinguinal varicocelectomy

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

subinguinal varicocelectomy

exision or preservation of spermatic cord lipoma during subinguinal varicocelectomy

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult infertile males
* Clinical varicocele
* Semen analysis show oligo-athenospermia

Exclusion Criteria

* Adolescent varicocele
* Recurrent varicocele
* Presence of inguinal hernia
* Azospermic patients
Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Tanta University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ahmed Zoeir

faculty of medicine, Tanta, ElGeish street, Egypt

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ahmed Zoeir

Tanta, Gharbia Governorate, Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Ahmed Zoeir

Role: primary

+201008634198

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

36137/12/22

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.